USA flag logo/image

An Official Website of the United States Government

Company Information:

Name: GLYCOSENSORS AND DIAGNOSTICS, LLC
Address: GLYCOSENSORS AND DIAGNOSTICS, LLC
ATHENS, GA 30602-1514
Located in HUBZone: No
Woman-Owned: No
Minority-Owned: No
Phone: N/A

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $248,819.00 2
SBIR Phase II $999,970.00 1
STTR Phase I $200,361.00 1
STTR Phase II $1,462,149.00 1

Award List:

High-specificity affinity reagents for N-glycosylation site mapping and glycomics

Award Year / Program / Phase: 2009 / STTR / Phase I
Agency: HHS
Research Institution: UNIVERSITY OF GEORGIA (UGA)
Principal Investigator: Robert J. Woods
Award Amount: $200,361.00
RI Contact: N/A
Abstract:
DESCRIPTION (provided by applicant): Glycans have several distinct properties that make them excellent targets for disease biomarkers. Firstly, the location of the glycans on the cell surface makes them the first point of contact of cellular interactions a nd thus crucial in the control of normal… More

SBIR TOPIC 294 PHASE 1 - DEVELOPMENT OF GLYCOSYLATION - SPECIFIC RESEARCH

Award Year / Program / Phase: 2011 / SBIR / Phase I
Agency: HHS
Principal Investigator: Lori Yang – 706-549-4484
Award Amount: $148,851.00
Abstract:
The long term objectives of this proposal are to demonstrate the utility of a new class of high-specificity high-affinity proteins called Lectenz as research reagents for use in recognition of disease- or cancer-related glycosylation sites. The specific aims are to create a reagent that is… More

In-process glycoprofiling during recombinant therapeutic glycoprotein production

Award Year / Program / Phase: 2012 / SBIR / Phase I
Agency: HHS
Principal Investigator: Loretta Yang – 706-542-4454
Award Amount: $99,968.00
Abstract:
DESCRIPTION (provided by applicant): The biologics market is the most rapidly growing sector of the pharmaceutical industry, and the US Food and Drug Administration (FDA), as well as the European Medicines Agency (EMEA), requires that the glycoprofiles ofall such therapeutic glycoproteins and… More

High-specificity affinity reagents for N-glycosylation site mapping and glycomics

Award Year / Program / Phase: 2013 / STTR / Phase II
Agency: HHS
Research Institution: UNIVERSITY OF GEORGIA RESEARCH FOUNDATION
Principal Investigator: Robert J. Woods – 706-542-4454
Award Amount: $1,462,149.00
RI Contact:
Abstract:
DESCRIPTION: Glycans have several distinct properties that make them excellent targets for disease biomarkers. Firstly, the location of the glycans on the cell surface makes them the first point of contact of cellular interactions and thus crucial in thecontrol of normal metabolic processes. Cell… More

SBIR PHASE II TOPIC 294: DEVELOPMENT OF RESEARCH REAGENTS SPECIFIC FOR O-GLCNAC (

Award Year / Program / Phase: 2013 / SBIR / Phase II
Agency: HHS
Principal Investigator: Lori Yang – 706-549-4484
Award Amount: $999,970.00
Abstract:
Not Available